FDA warns of steroids in vitamin B supplement

(AP)—The Food and Drug Administration is warning consumers to avoid a vitamin B dietary supplement from Healthy Life Chemistry by Purity First because it contains two potentially dangerous anabolic steroids.

The agency says the company's B-50 supplements tested positive for methasterone and dimethazine, two steroids sometimes used illegally by bodybuilders. Neither ingredient is listed on the product's labeling.

Federal regulators have received 29 reports of side effects connected with the product, including fatigue, muscle cramping and pain. Some of the cases have resulted in hospitalization, but there have been no reports of death or liver failure.

The product is manufactured by Mira Health Products Ltd. of Farmingdale, N.Y. and sold online and in stores. The FDA says the company has declined a government request to voluntarily recall the product.

5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

FDA warns consumers of dangers of the stimulant DMAA

Apr 15, 2013

(HealthDay)—The U.S. Food and Drug Administration is attempting to halt distribution of dietary supplements that contain the stimulant dimethylamylamine (DMAA), following reports of illness and death associated ...

US cracks down on illegal diabetes remedies

Jul 23, 2013

(AP)—The Food and Drug Administration is cracking down on more than a dozen U.S. and foreign companies that market illegal treatments for diabetes, ranging from bogus dietary supplements to prescription ...

US warns of drugs in Reumofan dietary supplements

Aug 21, 2012

(AP) — The U.S. Food and Drug Administration is warning consumers not to use Reumofan dietary supplements, after receiving reports of bleeding, stroke and death among Americans taking the Mexico-manufactured pills.

Recommended for you

FDA warning: men's testosterone drugs overused (Update)

Mar 03, 2015

The Food and Drug Administration is warning doctors against over-prescribing testosterone-boosting drugs for men, saying the popular treatments have not been established as safe or effective for common age-related ...

Early benefit assessment increases transparency for study data

Mar 03, 2015

Four years have passed since the introduction of the German Act on the Reform of the Market for Medicinal Products (AMNOG). AMNOG was primarily aimed at containing the increasing drug expenditure of the statutory health insurance ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.